Type 1 Diabetic Akita Mouse Hearts Are Insulin Sensitive but Manifest Structurally Abnormal Mitochondria That Remain Coupled Despite Increased Uncoupling Protein 3
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE— Fatty acid–induced mitochondrial uncoupling and oxidative stress have been proposed to reduce cardiac efficiency and contribute to cardiac dysfunction in type 2 diabetes. We hypothesized that mitochondrial uncoupling may also contribute to reduced cardiac efficiency and contractile dysfunction in the type 1 diabetic Akita mouse model (Akita). RESEARCH DESIGN AND METHODS— Cardiac function and substrate utilization were determined in isolated working hearts and in vivo function by echocardiography. Mitochondrial function and coupling were determined in saponin-permeabilized fibers, and proton leak kinetics was determined in isolated mitochondria. Hydrogen peroxide production and aconitase activity were measured in isolated mitochondria, and total reactive oxygen species (ROS) were measured in heart homogenates. RESULTS— Resting cardiac function was normal in Akita mice, and myocardial insulin sensitivity was preserved. Although Akita hearts oxidized more fatty acids, myocardial O2 consumption was not increased, and cardiac efficiency was not reduced. ADP-stimulated mitochondrial oxygen consumption and ATP synthesis were decreased, and mitochondria showed grossly abnormal morphology in Akita. There was no evidence of oxidative stress, and despite a twofold increase in uncoupling protein 3 (UCP3) content, ATP-to-O ratios and proton leak kinetics were unchanged, even after perfusion of Akita hearts with 1 mmol/l palmitate. CONCLUSIONS— Insulin-deficient Akita hearts do not exhibit fatty acid–induced mitochondrial uncoupling, indicating important differences in the basis for mitochondrial dysfunction between insulin-responsive type 1 versus insulin-resistant type 2 diabetic hearts. Increased UCP3 levels do not automatically increase mitochondrial uncoupling in the heart, which supports the hypothesis that fatty acid–induced mitochondrial uncoupling as exists in type 2 diabetic hearts requires a concomitant increase in ROS generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Conversely, this group noted a decrease in ROS production from heart mitochondria of an insulin-deficient model, the Akita mouse, which more closely resembles human type 1 diabetes (42).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [42]
In the citing paper
“In the Akita T1D mouse model, which develops diabetes as a consequence of a single-base pair substitution in Ins2, maximal ADPstimulated mitochondrial respiration and ATP synthesis decreased despite unchanged ROS emission in cardiac tissue (58).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [58]
In the citing paper
“The ATP production rate was reduced on the complex I substrates but in proportion to reduced oxygen consumption, explaining the lack of change in the indices of respiratory coupling.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [42]
In the citing paper
“Coupling of oxidation and phosphorylation was not altered on any substrate, as assessed with ADP/O ratios or with proton-leak kinetics.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [42]
In the citing paper
“These authors reported decreased state 3 respiration on complex I substrates pyruvate and glutamate but not on palmitoyl carnitine.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stereological Principles for Morphometry in Electron Microscopic Cytology
Weibel, E. R. (1969) · International Review of Cytology · doi:10.1016/s0074-7696(08)61637-x · Cited by 1,946 · cited 1×
“Mitochondrial volume density and number were analyzed by stereology in a blinded fashion using the point counting method (6; 25).”
MethodDilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789 · cited 1×
“9 Interestingly, impaired mitochondrial morphology in the type 1 diabetic OVE26 mouse can be normalized by overexpression of MnSOD or catalase in the heart, but MnSOD-deficient mice die from early dilated cardiomyopathy and have normal cardiac mitochondrial morphology (30-32).”
BackgroundMitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice
Larsson, N.-G., Wang, J., Wilhelmsson, H., Oldfors, A., Rustin, P., Lewandoski, M., Barsh, G. S., & Clayton, D. A. (1998) · Nature Genetics · doi:10.1038/ng0398-231 · Cited by 1,594 · cited 1×
“In other transgenic models, knockout of the mitochondrial transcription factor A leads to reduced mitochondrial DNA replication and transcription, and enlarged mitochondria with abnormal cristae morphology, and combined deletion of the cardiac insulin and IGF1 receptor results in impaired OXPHOS gene transcription and…”
BackgroundSuperoxide activates mitochondrial uncoupling proteins
Echtay, K. S., Roussel, D., St-Pierre, J., Jekabsons, M. B., Cadenas, S., Stuart, J. A., Harper, J. A., Roebuck, S. J., Morrison, A., Pickering, S., et al. (2002) · Nature · doi:10.1038/415096a · Cited by 1,382 · cited 2×
“Superoxide increases proton conductance by UCP3 in isolated rat skeletal muscle mitochondria, and lipid peroxidation products, such as hydroxynonenal, increase proton leak in isolated mitochondria from multiple tissues, including the heart, via UCPs and adenine nucleotide translocator (7,24).”
BackgroundPeterson, L. R., Herrero, P., Schechtman, K. B., Racette, S. B., Waggoner, A. D., Kisrieva-Ware, Z., Dence, C., Klein, S., Marsala, J., Meyer, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127959.28627.f8 · Cited by 656 · cited 1×
“Reduced cardiac efficiency is a well-described characteristic of type 2 diabetic hearts in animal models and humans (3,28).”
BackgroundOxidative damage during aging targets mitochondrial aconitase
Yan, L.-J., Levine, R. L., & Sohal, R. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11168 · Cited by 620 · cited 1×
“Activity of mitochondrial aconitase was measured in isolated mitochondria as described previously (27).”
MethodA signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling
Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero‐Otín, M., Pamplona, R., Vidal‐Puig, A. J., Wang, S., Roebuck, S. J., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg412 · Cited by 597
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., et al. (2007) · Diabetes · doi:10.2337/db07-0481 · Cited by 586 · cited 10×
“mol/l palmitoyl carnitine as previously described (6,24).”
BackgroundMethodInfluentialSelf-citationBuchanan, J., Mazumder, P. K., Hu, P., Chakrabarti, G., Roberts, M. W., Yun, U. J., Cooksey, R. C., Litwin, S. E., & Abel, E. D. (2005) · Endocrinology · doi:10.1210/en.2005-0938 · Cited by 555 · cited 2×
“Free fatty acid concentrations, triacylglycerol levels, and blood glucose levels were measured as previously described (4).”
BackgroundMethodSelf-citationYoshioka, M., Kayo, T., Ikeda, T., & Koizuni, A. (1997) · Diabetes · doi:10.2337/diab.46.5.887 · Cited by 534 · cited 3×
“This mouse develops diabetes as a consequence of a single base pair substitution in the Ins2 gene, resulting in improper folding of proinsulin, which leads to protein aggregate–induced endoplasmic reticulum stress in pancreatic islets (19,20) and eventual -cell failure (19).”
BackgroundInfluential
Cited by
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807
Molecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
“Interestingly, FA-induced ROS-mediated mitochondrial uncoupling does not occur in certain mouse models of type 1 diabetes, such as the Akita diabetic mouse, indicating that some mechanisms governing changes in myocardial energy metabolismmight be distinct in type 1 vs type 2 diabetes [67].”
Self-citationSivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
“Interestingly, UCP3 expression is increased in insulindeficient diabetic rodents but with no associated increase (42) or an actual decrease (134) in the proton conductance (decrease in the proton leak) of isolated mitochondria incubated MITOCHONDRIA AND DIABETES 551”
InfluentialDiabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Self-citationBasic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Self-citationHuynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Insulin Signaling and Heart Failure
Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 418
Self-citationTsushima, K., Bugger, H., Wende, A. R., Soto, J., Jenson, G. A., Tor, A. R., McGlauflin, R., Kenny, H. C., Zhang, Y., Souvenir, R., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311307 · Cited by 330
Self-citationBoudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.792101 · Cited by 301
Self-citationRodent models of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001941 · Cited by 285
“…genes encoding for subunits of mitochondrial oxidative phosphorylation (OXPHOS) complexes is reduced; OXPHOS and TCA cycle proteins are reduced; and the density of mitochondrial cristae is severely decreased, despite an increase in mitochondrial content (Bugger et al., 2008; Bugger et al., 2009).”
BackgroundInfluentialSelf-citationMitochondria in the diabetic heart
Bugger, H., & Abel, E. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq239 · Cited by 260
Self-citationProteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure
Bugger, H., Schwarzer, M., Chen, D., Schrepper, A., Amorim, P. A., Schoepe, M., Nguyen, T. D., Mohr, F. W., Khalimonchuk, O., Weimer, B. C., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp344 · Cited by 211
“Besides heart failure, downregulation of ETC subunits due to reduced PGC-1a levels has also been proposed to contribute to mitochondrial dysfunction in Type 1 diabetic Akita hearts and skeletal muscle in human Type 2 diabetes.(16,23) Thus, the concept is discussed that the downregulation of ETC subunits due to reduced…”
BackgroundMethodSelf-citationPrevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
Chacko, B. K., Reily, C., Srivastava, A., Johnson, M. S., Ye, Y., Ulasova, E., Agarwal, A., Zinn, K. R., Murphy, M. P., Kalyanaraman, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100308 · Cited by 204
SIRT3 deficiency impairs mitochondrial and contractile function in the heart
Koentges, C., Pfeil, K., Schnick, T., Wiese, S., Dahlbock, R., Cimolai, M. C., Meyer-Steenbuck, M., Cenkerova, K., Hoffmann, M. M., Jaeger, C., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0493-6 · Cited by 200
Self-citationAltered mitochondrial function in insulin-deficient and insulin-resistant states
Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120843 · Cited by 202
“In the Akita T1D mouse model, which develops diabetes as a consequence of a single–base pair substitution in Ins2, maximal ADPstimulated mitochondrial respiration and ATP synthesis decreased despite unchanged ROS emission in cardiac tissue (58).”
Of mice and men: models and mechanisms of diabetic cardiomyopathy
Riehle, C., & Bauersachs, J. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 196
“Importantly, fatty acid-mediated mitochondrial uncoupling, increased ROS levels and decreased cardiac efficiency are not present in T1D Akita mice [34], which is in contrast to T2D ob/ob and db/db mice [29, 120].”
ResultMitochondrial Hormesis and Diabetic Complications
Sharma, K. (2015) · Diabetes · doi:10.2337/db14-0874 · Cited by 193
Tissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
Bugger, H., Chen, D., Riehle, C., Soto, J., Theobald, H. A., Hu, X. X., Ganesan, B., Weimer, B. C., & Abel, E. D. (2009) · Diabetes · doi:10.2337/db09-0259 · Cited by 180
“Oxidative damage unlikely contributes to reduced respiration rates since mitochondrial reactive oxygen species production and oxidative damage are not increased in hearts of the Akita mouse model (3).”
BackgroundMethodInfluentialSelf-citationTherapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Byrne, N. J., Rajasekaran, N. S., Abel, E. D., & Bugger, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.046 · Cited by 174
“Interestingly, others have observed reductions in lipid peroxidation in ALX-induced T1D [51] and in contrast to the other models, the Akita mouse model has decreased mitochondrial hydrogen peroxide generation and no induction of antioxidant defense pathways [52,53].”
ResultSelf-citationMizuno, M., Kuno, A., Yano, T., Miki, T., Oshima, H., Sato, T., Nakata, K., Kimura, Y., Tanno, M., & Miura, T. (2018) · Physiological Reports · doi:10.14814/phy2.13741 · Cited by 169
“Although the relationship between functional abnormality and morphological changes of mitochondria in the natural history of diabetes mellitus has not been clarified, an increase in the number of mitochondria with a slight reduction in their size appears to precede more severe changes such as swelling of mitochondria,…”
BackgroundMitochondrial NAD + /NADH Redox State and Diabetic Cardiomyopathy
Berthiaume, J. M., Kurdys, J. G., Muntean, D. M., & Rosca, M. G. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7415 · Cited by 168
Basu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., & Kassiri, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00452.2009 · Cited by 161
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Hölscher, M., Bode, C., & Bugger, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122136 · Cited by 160
Self-citationMitochondrial Mechanisms in Septic Cardiomyopathy
Cimolai, M. C., Álvarez, S., Bode, C., & Bugger, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817763 · Cited by 167
Self-citationJoubert, M., Jagu, B., Montaigne, D., Marechal, X., Tesse, A., Ayer, A., Dollet, L., Le May, C., Toumaniantz, G., Manrique, A., et al. (2017) · Diabetes · doi:10.2337/db16-0733 · Cited by 151
Ni, R., Zheng, D., Xiong, S., Hill, D. J., Sun, T., Gardiner, R. B., Fan, G., Lu, Y., Abel, E. D., Greer, P. A., et al. (2015) · Diabetes · doi:10.2337/db15-0963 · Cited by 150
“Although some type 1 diabetic animals did not exhibit increased mitochondrial superoxide generation in the heart (21,22), selective inhibition of mitochondrial ROS production reduces adverse cardiac changes in type 1 diabetes models (23,24), supporting a critical role of mitochondrial ROS.”
BackgroundSelf-citationThe regulation and turnover of mitochondrial uncoupling proteins
Azzu, V., Jastroch, M., Divakaruni, A. S., & Brand, M. D. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.035 · Cited by 146
Mitochondrial stress and the pathogenesis of diabetic neuropathy
Fernyhough, P., Chowdhury, S. R., & Schmidt, R. E. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.55 · Cited by 158
Baseler, W. A., Dabkowski, E. R., Williamson, C. L., Croston, T. L., Thapa, D., Powell, M. J., Trust T. Razunguzwa, & Hollander, J. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00423.2010 · Cited by 151
Mitochondrial Morphology in Metabolic Diseases
Galloway, C. A., & Yoon, Y. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4779 · Cited by 140
“Despite their abnormal cardiac pathology, physiologically, they demonstrate very subtle contractile defects and retain mitochondrial coupling while lacking enhanced production of ROS and the resulting oxidative stress (18).”
Mitochondrial Mechanisms in Diabetic Cardiomyopathy
Gollmer, J., Zirlik, A., & Bugger, H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0185 · Cited by 144
Self-citationTeshima, Y., Takahashi, N., Nishio, S., Saito, S., Kondo, H., Fukui, A., Aoki, K., Yufu, K., Nakagawa, M., & Saikawa, T. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1187 · Cited by 130
Suzuki, H., Kayama, Y., Sakamoto, M., Iuchi, H., Shimizu, I., Yoshino, T., Katoh, D., Nagoshi, T., Tojo, K., Minamino, T., et al. (2014) · Diabetes · doi:10.2337/db13-1896 · Cited by 141
mIGF‐1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart
Vinciguerra, M., Santini, M. P., Martinez, C., Pazienza, V., Claycomb, W. C., Giuliani, A., & Rosenthal, N. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00766.x · Cited by 122
“Aconitase activity was measured in isolated heart mitochondria as previously described (Bugger et al., 2008).”
MethodJagannathan, R., Thapa, D., Nichols, C. E., Shepherd, D. L., Stricker, J. C., Croston, T. L., Baseler, W. A., Lewis, S. E., Martinez, I., & Hollander, J. M. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.115.001067 · Cited by 119
New Molecular Insights of Insulin in Diabetic Cardiomyopathy
Westermeier, F., Riquelme, J. A., Pavez, M., Garrido, V., Díaz, A., Verdejo, H. E., Castro, P. F., García, L., & Lavandero, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00125 · Cited by 111
“In contrast, the type 1 diabetic Akita mouse model (Akita) is characterized by normal cardiac function and preservedmyocardial insulin sensitivity, and does not exhibit FAinduced mitochondrial uncoupling (Bugger et al., 2008).”
BackgroundWang, S., Zhao, Z., Fan, Y., Zhang, M., Feng, X., Lin, J. M., Hu, J., Cheng, Z., Sun, C., Liu, T., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.009 · Cited by 111
Pathophysiological Fundamentals of Diabetic Cardiomyopathy
Hu, X., Bai, T., Xu, Z., Liu, Q., Zheng, Y., & Cai, L. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160021 · Cited by 122
Self-citationInsulin signaling in the heart
Abel, E. D. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00158.2021 · Cited by 108
Self-citationShabalina, I. G., Hoeks, J., Kramarova, T. V., Schrauwen, P., Cannon, B., & Nedergaard, J. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.033 · Cited by 111
Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart
Pham, T., Loiselle, D. S., Power, A., & Hickey, A. J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00006.2014 · Cited by 103
Vazquez, E. J., Berthiaume, J. M., Kamath, V. G., Achike, O., Buchanan, E., Montano, M. M., Chandler, M. P., Miyagi, M., & Rosca, M. G. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv183 · Cited by 103
Anedda, A., López-Bernardo, E., Acosta‐Iborra, B., Suleiman, M. S., Landázuri, M. O., & Cadenas, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.007 · Cited by 100
Pulinilkunnil, T., Kienesberger, P. C., Nagendran, J., Waller, T. J., Young, M. E., Kershaw, E. E., Korbutt, G. S., Haemmerle, G., Zechner, R., & Dyck, J. R. B. (2013) · Diabetes · doi:10.2337/db12-0927 · Cited by 97
Prandi, F. R., Evangelista, I., Sergi, D., Palazzuoli, A., & Romeo, F. (2022) · Heart Failure Reviews · doi:10.1007/s10741-021-10200-y · Cited by 95
Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
Copier, C. U., León, L. E., Fernández, M., Contador, D., & Calligaris, S. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-13875-2 · Cited by 89
Chowdhury, S. K. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.06.007 · Cited by 82
Joubert, M., Manrique, A., Cariou, B., & Prieur, X. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2018.07.003 · Cited by 81
Edwards, K. S., Ashraf, S., Lomax, T. M., Wiseman, J. M., Hall, M. E., Gava, F. N., Hall, J. E., Hosler, J. P., & Harmancey, R. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0707-9 · Cited by 81
Superoxide and Respiratory Coupling in Mitochondria of Insulin-Deficient Diabetic Rats
Herlein, J. A., Fink, B. D., O'Malley, Y., & Sivitz, W. I. (2009) · Endocrinology · doi:10.1210/en.2008-0404 · Cited by 77
Thapa, D., Nichols, C. E., Lewis, S. E., Shepherd, D. L., Jagannathan, R., Croston, T. L., Tveter, K. J., Holden, A. A., Baseler, W. A., & Hollander, J. M. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.008 · Cited by 82
Updating Experimental Models of Diabetic Cardiomyopathy
Fuentes‐Antrás, J., Picatoste, B., Gómez‐Hernández, A., Egido, J., Tuñón, J., & Lorenzo, Ó. (2015) · Journal of Diabetes Research · doi:10.1155/2015/656795 · Cited by 76
“However, despitemorphological aberrations, mitochondrial number and antioxidant defences remained unchanged, and the absence of mitochondrial uncoupling was evidenced by unaffected ATP-to-O 2 ratio [71].”
Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0249 · Cited by 77
Protective Mechanisms of Mitochondria and Heart Function in Diabetes
Aon, M. A., Tocchetti, C. G., Bhatt, N., Paolocci, N., & Cortassa, S. C. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6123 · Cited by 78
Zhou, C., Pridgen, B., King, N., Xu, J., & Breslow, J. L. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m014092 · Cited by 70
Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
Mizamtsidi, M., Paschou, S. Α., Grapsa, J., & Vryonidou, A. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12673 · Cited by 76
Diabetic Cardiomyopathy: A Brief Summary on Lipid Toxicity
Ke, J., Pan, J., Lin, H., & Gu, J. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14224 · Cited by 70
“chondrial oxidative capacity, whereas genetic type 1 diabetic mice (Akita mice) do not exhibit cardiac efficiency impairment or mitochondrial uncoupling.(7) In both T1DM and T2DM, a lack”
BackgroundBoudina, S., Sena, S., Sloan, C., Tebbi, A., Han, Y. H., O'Neill, B. T., Cooksey, R. C., Jones, D., Holland, W. L., McClain, D. A., et al. (2012) · Endocrinology · doi:10.1210/en.2011-2147 · Cited by 66
Self-citationLumini-Oliveira, J., Magalhães, J., Pereira, C. V., Moreira, A. C., Oliveira, P. J., & Ascensão, A. (2011) · Mitochondrion · doi:10.1016/j.mito.2010.07.005 · Cited by 66
Genetic loss of insulin receptors worsens cardiac efficiency in diabetes
Bugger, H., Riehle, C., Jaishy, B. P., Wende, A. R., Tuinei, J., Chen, D., Soto, J. E., Pires, K. M. P., Boudina, S., Theobald, H. A., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.02.001 · Cited by 69
“A reduction in cardiac size is a well-described characteristic of poorly controlled type 1 diabetes [6, 15].”
BackgroundMethodSelf-citationPolina, I., Jansen, H. J., Li, T., Moghtadaei, M., Bohne, L. J., Liu, Y., Krishnaswamy, P., Egom, E. E., Belke, D. D., Rafferty, S. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914853117 · Cited by 60
“S3 and Table S9) demonstrates that Akita mice did not display substantial changes in ventricular structure or function, which is consistent with prior studies (24).”
ResultBoudina, S., Han, Y. H., Pei, S., Tidwell, T. J., Henrie, B., Tuinei, J., Olsen, C. D., Sena, S., & Abel, E. D. (2012) · Diabetes · doi:10.2337/db12-0063 · Cited by 64
Self-citationHensel, K. O., Grimmer, F., Roskopf, M., Jenke, A., Wirth, S., & Heusch, A. (2015) · Journal of Diabetes Research · doi:10.1155/2016/2583747 · Cited by 68
“Accountable pathologic mechanisms are diabetes-induced loss of t-tubule structure [14], formation of advanced glycosylation end products with subsequent pathologically increased collagen cross-linking [70], altered mitochondrial energetics [71], and several other metabolic imbalances [11, 72].”
BackgroundVadvalkar, S. S., Baily, C. N., Matsuzaki, S., West, M., Tesiram, Y. A., & Humphries, K. M. (2013) · Biochemical Journal · doi:10.1042/bj20121038 · Cited by 58
Kuramoto, K., Sakai, F., Yoshinori, N., Nakamura, T. Y., Wakabayashi, S., Kojidani, T., Haraguchi, T., Hirose, F., & Osumi, T. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00133-14 · Cited by 61
Insulin Signaling Regulates Mitochondrial Function in Pancreatic β-Cells
Liu, S., Okada, T., Assmann, A., Soto, J., Liew, C. W., Bugger, H., Shirihai, O. S., Abel, E. D., & Kulkarni, R. N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007983 · Cited by 58
Self-citation4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes
López-Bernardo, E., Anedda, A., Sánchez-Pérez, P., Acosta‐Iborra, B., & Cadenas, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.032 · Cited by 61
Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
Sung, M. M. Y., Hamza, S. M., & Dyck, J. R. B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6305 · Cited by 59
“Type 1 diabetes Streptozotocin Y (85, 211) Y (85, 149) Y (112) [ (112) Y (112) [ (211) Ins2 + / - Akita Y (35) Y (35, 36) — (35) [ (35) Y (35) [ (211) OVE26 Y (234, 284) Y (234) Y (284)”
The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy
Sanganalmath, S. K., Dubey, S., Veeranki, S., Narisetty, K. K., & Krishnamurthy, P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01755-1 · Cited by 58
Diabetes Mellitus and Heart Failure
Tousoulis, D., Oikonomou, E. K., Siasos, G., & Stefanadis, C. (2014) · European Cardiology Review · doi:10.15420/ecr.2014.9.1.37 · Cited by 63
“They can induce cardiomyocyte hypertrophy and death in vitro, which are prevented by sodium-hydrogen exchanger-1 inhibition.29 MicroRNAs are also differentially expressed in myocardial tissues from subjects with diabetic cardiomyopathy compared with non-diabetic HF, and specific patterns have been recognised.30–32 The…”
BackgroundInfluentialNakagawa, T., Sánchez‐Lozada, L. G., Andrés-Hernando, A., Kojima, H., Kasahara, M., Rodríguez‐Iturbe, B., Bjornstad, P., Lanaspa, M. A., & Johnson, R. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694457 · Cited by 61
The metabolic syndrome in heart failure: insights to specific mechanisms
Gargiulo, P., Marsico, F., Renga, F., Dell’Aversana, S., Esposito, I., Marciano, C., Dellegrottaglie, S., Filardi, P. P., & Paolillo, S. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09838-6 · Cited by 62
“In addition, the hearts of humans with MS are characterized by increased fatty acid metabolism and oxidation, which is considered a pathophysiological mechanism in the development of HF [13].”
BackgroundHarmancey, R., Vasquez, H. G., Guthrie, P. H., & Taegtmeyer, H. (2013) · The FASEB Journal · doi:10.1096/fj.13-234914 · Cited by 56
Globular CTRP3 promotes mitochondrial biogenesis in cardiomyocytes through AMPK/PGC-1α pathway
Zhang, C., Feng, H., Li, L., Wang, J.-Y., Wu, D., Hao, Y., Wang, Z., Zhang, Y., & Wu, L. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.10.022 · Cited by 54
Ran, J., Guo, X., Li, Q., Mei, G., & Gancheng, L. (2009) · Platelets · doi:10.3109/09537100903288422 · Cited by 52
“Other researchers also reported that uncoupling protein 2 and 3 expression are up-regulated in kidney proximal tubular cells and heart cells of streptozotocin (STZ)-induced rats [25] and type 1 diabetic Akita mice [26, 27].”
BackgroundEpoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic Cardiomyopathy
Romashko, M. D., Schragenheim, J., Abraham, N. G., & McClung, J. A. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.08.001 · Cited by 55
Preserved recovery of cardiac function following ischemia–reperfusion in mice lacking SIRT3
Koentges, C., Pfeil, K., Meyer-Steenbuck, M., Lother, A., Hoffmann, M. M., Odening, K. E., Hein, L., Bode, C., & Bugger, H. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0152 · Cited by 51
Self-citationKesherwani, V., Shahshahan, H. R., & Mishra, P. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182828 · Cited by 53
Roul, D., & Recchia, F. A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6311 · Cited by 51
Sun, Y., Teng, Z., Sun, X., Zhang, L., Chen, J., Wang, B., Lu, F., Liu, N., Yu, M., Peng, S., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2018 · Cited by 53
Haye, A., Ansari, M. A., Rahman, S. O., Shamsi, Y., Ahmed, D., & Sharma, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173376 · Cited by 50
Werbner, B., Tavakoli‐Rouzbehani, O. M., Fatahian, A. N., & Boudina, S. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.42 · Cited by 54
Self-citationCardiac contractile function and mitochondrial respiration in diabetes-related mouse models
Marciniak, C., Marechal, X., Montaigne, D., Nevière, R., & Lancel, S. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0118-7 · Cited by 46
Yoldaş, T., Örün, U. A., Sağsak, E., Aycan, Z., Kaya, Ö., Özgür, S., & Karademir, S. (2017) · Echocardiography · doi:10.1111/echo.13764 · Cited by 50
Diabetes-induced changes in cardiac voltage-gated ion channels
Öztürk, N., Uslu, S., & Özdemir, S. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i1.1 · Cited by 48
Maintenance of Enteral ACE2 Prevents Diabetic Retinopathy in Type 1 Diabetes
Prasad, R., Floyd, J. L., Dupont, M., Harbour, A., Adu-Agyeiwaah, Y., Asare‐Bediako, B., Chakraborty, D., Kichler, K., Rohella, A., Calzi, S. L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.322003 · Cited by 45
Mitochondrial inner membrane protein, Mic60/mitofilin in mammalian organ protection
Feng, Y., Madungwe, N. B., & Bopassa, J. C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27314 · Cited by 42
Holloway, G. P., Snook, L. A., Harris, R. J., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.198663 · Cited by 46
“In addition, mitochondria isolated from Akita mice are unaltered with respect to ATP synthesis rates, coupling, proton leak and number (Bugger et al. 2008).”
BackgroundLaRocca, T. J., Fabris, F., Chen, J., Benhayon, D. A., Zhang, S., McCollum, L. T., Schecter, A. D., Cheung, J. Y., Sobie, E. A., Hajjar, R. J., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01198.2011 · Cited by 41
Prandi, F. R., Lecis, D., Illuminato, F., Milite, M., Celotto, R., Lerakis, S., Romeo, F., & Barillà, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094589 · Cited by 42
“In T1DM, diabetic cardiomyopathy is characterized by preserved systolic function, the absence of cardiac hypertrophy [11] and increased cardiomyocyte autophagy compared to T2DM [12].”
BackgroundNabben, M., Shabalina, I. G., Moonen‐Kornips, E., van Beurden, D., Cannon, B., Schrauwen, P., Nedergaard, J., & Hoeks, J. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.04.003 · Cited by 45
Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms
Song, Y., Zhong, C., & Wu, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7051845 · Cited by 37
Animal Models of Dysregulated Cardiac Metabolism
Bugger, H., Byrne, N. J., & Abel, E. D. (2022) · Circulation Research · doi:10.1161/circresaha.122.320334 · Cited by 37
Self-citationAltered parasympathetic nervous system regulation of the sinoatrial node in Akita diabetic mice
Krishnaswamy, P. S., Egom, E. E. A., Moghtadaei, M., Jansen, H. J., Azer, J., Bogachev, O., Mackasey, M., Robbins, C., & Rose, R. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.024 · Cited by 37
Shehadeh, L. A., Robleto, E., & Lopaschuk, G. D. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00121.2025 · Cited by 37
Tocchetti, C. G., Stanley, B. A., Sivakumaran, V., Bedja, D., O'Rourke, B. P., Paolocci, N., Cortassa, S. C., & Aon, M. A. (2015) · Clinical Science · doi:10.1042/cs20150204 · Cited by 39
Application of Animal Models in Diabetic Cardiomyopathy
Lee, W. S., & Kim, J. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0285 · Cited by 38
de Giusti, C. J., Palomeque, J., & MATTIAZZI, A. R. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02650-y · Cited by 37
Research advances in the therapy of metabolic syndrome
Lin, Z., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364881 · Cited by 38
Metadata
- Authors
- Bugger, H., Boudina, S., Hu, X. X., Tuinei, J., Zaha, V. G., Theobald, H. A., Yun, U. J., McQueen, A. P., Wayment, B., Litwin, S. E., & Abel, E. D.
- Affiliations
- University of Utah (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-11-01
- Volume
- 57
- Issue
- 11
- Pages
- 2924-2932
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2570388
- OpenAlex
- W2141450595
- Cited by
- 182
- References
- 47
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 10 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 17 · 2017: 18 · 2016: 10 · 2015: 19 · 2014: 14 · 2013: 8 · 2012: 13
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (UO1 HL087947, U01HL087947, R01HL070070, UO1HL70525, U01HL070525)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- type 1 diabetes, diabetic cardiomyopathy, mitochondrial uncoupling, UCP3, mitochondrial dysfunction, fatty acid oxidation, cardiac efficiency, oxidative stress, reactive oxygen species, aconitase, mitochondrial morphology, proton leak, ATP production, palmitate
- MeSH terms
- Uncoupling Protein 2, Uncoupling Protein 3, Animals, Diabetes Mellitus, Type 1, Echocardiography, Insulin, Ion Channels, Male, Mice, Inbred C57BL, Microscopy, Electron, Mitochondria, Heart, Myocardium, Oxygen Consumption, RNA, Messenger, Blotting, Western, Reactive Oxygen Species, Oxidative Stress, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.